Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Weight Loss in Patients With Advanced Stage Pancreatic Cancer: Role of Serotonin and Effects of Telotristat Ethyl

NCT03910387 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT03910387
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03910387 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Weight Loss in Patients With Advanced Stage Pancreatic Cancer: Role of Serotonin and Effects of Telotristat Ethyl
Lead sponsor
Emory University
Phase
Phase 2
Overall status
Completed
Start date
April 17, 2019
Completion date
June 29, 2022
Enrollment
23 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced unresectable pancreatic adenocarcinoma, metastatic pancreatic adenocarcinoma, recurrent pancreatic adenocarcinoma, stage iii pancreatic cancer ajcc v8, stage iv pancreatic cancer ajcc v8